Optinose Inc (OPTN) Return on Assets ROA from the first quarter of 2025 to first quarter of 2024 and for the year 2025, Average High and Low, Fundamental Ratios from Mar 31 2025 to Mar 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Optinose Inc   (NASDAQ: OPTN)


Optinose Inc 's ROA from the first quarter of 2025 to the first quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Optinose Inc 's ROA in the first quarter of 2025?
Optinose Inc recorded a cumulative net loss of $-30 million during 12 months ending in the first quarter of 2025, resulting in a negative return on assets (ROA) of -23.62%.

However, within the Healthcare sector 415 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2025 quarter, so far to 3711, from total ROA ranking in the fourth quarter of 2024 at 4152.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter
Y / Y Total Assets Change 36.84 % 19.55 % 29.2 % 24.33 % -27.14 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -30 -22 -31 -41 -31
Return On Assets (TTM) -23.62 % -18.13 % -27.44 % -38.48 % -30.79 %
OPTN's Total Ranking # 3711 # 4152 # 3869 # 4103 # 4007
Total Assets (TTM) in million 115 129 131 132 84
Seq. Total Assets Change -11.06 % -1.71 % -0.65 % 57.54 % -22.3 %
Seq. Net Income Change - - - - -

OPTN's 5 Years Annual ROA >> Back to OPTN Management Effectiveness >> Compare OPTN ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 159
Sector # 416
Overall # 3660

Return On Assets Statistics
High Average Low
117.79 %
-38.87 %
-66.85 %
(Mar 31 2018)   (Jun 30 2020)



  News about Optinose Inc Return on Assets ROA

Optinose’s Prescription Surge Masks Financial Struggles: Can Strategic Restructuring Turn the Tide,

Article for The CSI MarketOptinose s Balancing Act: Prescription Growth Amid Financial Struggles and Strategic RestructuringIn the realm of pharmaceuticals and biotechnology, companies oftentimes navigate a precarious balance between pursuing ambitious innovations and meeting the stringent expectations of investors and stakeholders. Optinose Inc. (NASDAQ: OPTN), a company deeply entrenched in the treatment of chronic rhinosinusitis, is currently at a crossroads—a promising surge in prescription growth amid ongoing financial woes.Preliminary unaudited figures for the fourth quarter of 2024 have revealed that Optinose s XHANCE product, designed to alleviate chronic nasal inflammation, has generated net revenues of approximately $22.4 million. This figure marks a notable 20% increase in the growth rate of XHANCE prescriptions from the third quarter to the fourth quarter of 2024. In an industry where patient demand can drive company fortunes, this growth offers a semblance of optimism. Nevertheless, the pharmaceutical company continues to grapple with serious financial setbacks, having accrued a cumulative net loss of $31 million during the 12 months ending in the third quarter of 2024, resulting in a concerning return on assets (ROA) of -27.44%.



Financial Statements
Optinose Inc 's Assets $ 115 million OPTN's Balance sheet
Optinose Inc 's Income $ -22 million Quarterly OPTN's Income Statement
OPTN's Income by Division See OPTN's Income by Division



Annual Return On Assets (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020
Y / Y Total Assets Change 19.55 % -25.3 % -13.16 % -11.98 % 9.63 %
Total Assets in million 129 108 144 166 189
Y / Y Net Income Change - - - - -
Net Income in million -22 -35 -75 -82 -100
Annual Return On Assets -16.73 % -32.94 % -51.89 % -49.55 % -52.89 %

OPTN's 5 Years Annual ROA >> Back to OPTN Management Effectiveness >> Compare OPTN ROA to its Competitors



More Return On Assets Ratios
OPTN's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
OPTN's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for OPTN's Competitors
Subscribers only: Roa for Optinose Inc 's Suppliers
Subscribers only: Return On Assets for OPTN's Customers

You may also want to know
OPTN's Roi OPTN's Inventory Turnover Ratio OPTN's Growth Rates OPTN's Dividend Comparisons
OPTN's Profitability Ratios OPTN's Asset Turnover Ratio OPTN's Dividend Growth
OPTN's Roe OPTN's Valuation Ratios OPTN's Financial Strength Ratios OPTN's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2025, within Healthcare Sector ROA

Date modified: 2026-09-26T07:37:49+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.